National athletic trainers' association position statement: Skin diseases

Journal of Athletic Training

Volumn 45, Issue 4, 2010, Pages 411-428

  Zinder, Steven M ^a   Basler, Rodney S W ^b   Foley, Jack ^c   Scarlata, Chris ^d   Vasily, David B ^e  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Fremont Dermatology   (United States)

^c LEHIGH UNIVERSITY   (United States)

^d Cornell University ^*  (United States)

^e Aesthetica Cosmetic and Laser Center   (United States)

Author keywords

Carbuncle; Community associated methicillin resistant Staphylococcus aureus (CA MRSA); Folliculitis; Furuncle; Herpes simplex; Impetigo; Molluscum contagiosum; Nea capitis; Tinea corporis

Indexed keywords

BACTERIAL INFECTION; DISEASE TRANSMISSION; HAND WASHING; HEALTH EDUCATION; HUMAN; HYGIENE; MYCOSIS; PATIENT EDUCATION; REVIEW; SKIN DISEASE; SPORTS MEDICINE; STANDARD; UNITED STATES; VIRUS INFECTION;

BACTERIAL INFECTIONS; HANDWASHING; HEALTH EDUCATION; HUMANS; HYGIENE; MYCOSES; PATIENT EDUCATION AS TOPIC; SKIN DISEASES; SPORTS MEDICINE; UNITED STATES; VIRUS DISEASES;

EID: 77957126508     PISSN: 10626050     EISSN: None     Source Type: Journal    
DOI: 10.4085/1062-6050-45.4.411     Document Type: Article

References (181)

1. Adams BB. Dermatologic disorders of the athlete. Sports Med. 2002;32(5):309-321.
2. Turbeville SD, Cowan LD, Greenfield RA. Infectious disease outbreaks in competitive sports: a review of the literature. Am J Sports Med. 2006;34(11):1860-1865.
3. Ebell MH, Siwek J, Weiss BD, et al. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. Am Fam Physician. 2004;69(3):548-556.
4. Allen HB, Honig PJ, Leyden JJ, McGinley KJ. Selenium sulfide: adjunctive therapy for tinea capitis. Pediatrics. 1982;69(1):81-83.
5. Commens CA. Cutaneous transmission of molluscum contagiosum during orienteering competition. Med J Aust. 1987;146(2):117.
6. Srinivasan A, Wolfenden LL, Song X, et al. An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes. N Engl J Med. 2003;348(3):221-227.
7. Beekmann SE, Vaughn TE, McCoy KD, et al. Hospital bloodborne pathogens programs: program characteristics and blood and body fluid exposure rates. Infect Control Hosp Epidemiol. 2001;22(2): 73-82.
8. Tokars JI, McKinley GF, Otten J, et al. Use and efficacy of tuberculosis infection control practices at hospitals with previous outbreaks of multidrug-resistant tuberculosis. Infect Control Hosp Epidemiol. 2001;22(7):449-455.
9. Bhalla A, Pultz NJ, Gries DM, et al. Acquisition of nosocomial pathogens on hands after contact with environmental surfaces near hospitalized patients. Infect Control Hosp Epidemiol. 2004;25(2): 164-167.
10. Centers for Disease Control and Prevention. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep. 2003;52(RR10):1-42.
11. Vasily DB, Foley JJ. More on tinea corporis gladiatorum. J Am Acad Dermatol. 2002;46:1-2.
12. Decker MD, Lybarger JA, Vaughn WK, Hutcheson RH Jr, Schaffner W. An outbreak of staphylococcal skin infections among river rafting guides. Am J Epidemiol. 1986;124(6):969-976.
13. Crawford SE, Boyle-Vavra S, Daum RS. Community associated methicillin-resistant Staphylococcus aureus. In: Hooper DC, Scheld M, eds. Emerging Infections. Vol 7. Washington, DC: ASM Press; 2007:153-179.
14. Frazee BW, Lynn J, Charlebois ED, Lambert L, Lowery D, Perdreau-Remington F. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med. 2005;45(3):311-320.
15. Creech CB 2nd, Kernodle DS, Alsentzer A, Wilson C, Edwards KM. Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J. 2005;24(7): 617-621.
16. Centers for Disease Control and Prevention. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections-Los Angeles County, California, 2002-2003. MMWR Morb Mortal Wkly Rep. 2003;52(5):88.
17. Bischoff WE, Reynolds TM, Sessler CN, Edmond MB, Wenzel RP. Handwashing compliance by health care workers: the impact of introducing an accessible, alcohol-based hand antiseptic. Arch Intern Med. 2000;160(7):1017-1021.
18. Larson EL, Aiello AE, Bastyr J, et al. Assessment of two hand hygiene regimens for intensive care unit personnel. Crit Care Med. 2001;29(5):944-951.
19. Stacey A, Atkins B. Infectious diseases in rugby players: incidence, treatment and prevention. Sports Med. 2000;29(3):211-220.
20. Brandrup F, Asschenfeldt P. Molluscum contagiosum-induced comedo and secondary abscess formation. Pediatr Dermatol. 1989;6(2):118-121.
21. Lindenmayer JM, Schoenfeld S, O'Grady R, Carney JK. Methicillinresistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch Intern Med. 1998;158(8):895-899.
22. Kohn LT, Corrigan J, Donaldson MS. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 2000.
23. Carpenter CF, Chambers HF. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis. 2004;38(7):994-1000.
24. Malik RE, Cooper RA, Griffith CJ. Use of audit tools to evaluate the efficacy of cleaning systems in hospitals. Am J Infect Control. 2003;31(3):181-187.
25. Begier EM, Frenette K, Barrett NL, et al. A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clin Infect Dis. 2004;39(10):1446-1453.
26. Theos AU, Cummins R, Silverberg NB, Paller AS. Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial. Cutis. 2004; 74(2):134-138, 141-142.
27. Miller LG, Perdreau-Remington F, Bayer AS, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin- susceptible S aureus infection: a prospective investigation. Clin Infect Dis. 2007;44(4):471-482.
28. Matis WL, Triana A, Shapiro R, Eldred L, Polk BF, Hood AF. Dermatologic findings associated with human immunodeficiency virus infection. J Am Acad Dermatol. 1987;17(5, pt 1):746-751.
29. Ordoukhanian E, Lane AT. Warts and molluscum contagiosum: beware of treatments worse than the disease. Postgrad Med. 1997;101(2):223-226, 229-232, 235.
30. Pronovost PJ, Nolan T, Zeger S, Miller M, Rubin H. How can clinicians measure safety and quality in acute care? Lancet. 2004;363(9414):1061-1067.
31. Siegel JD, Rhinehart E, JacksonM, Chiarello L. Health Care Infection Control Practices Advisory Committee: 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007;35(10)(suppl 2):S65-S164.
32. Bonten MJ, Kollef MH, Hall JB. Risk factors for ventilatorassociated pneumonia: from epidemiology to patient management. Clin Infect Dis. 2004;38(8):1141-1149.
33. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R; CDC; Healthcare Infection Control Practices Advisory Committee. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Morb Mortal Wkly Rep. 2003;53(RR-3):1-36.
34. Macartney KK, Gorelick MH, Manning ML, Hodinka RL, Bell LM. Nosocomial respiratory syncytial virus infections: the costeffectiveness and cost-benefit of infection control. Pediatrics. 2000;106(3):520-526.
35. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycinresistant Enterococcus in health care facilities in a region. N Engl J Med. 2001;344(19):1427-1433.
36. Burke JP. Infection control: a problem for patient safety. N Engl J Med. 2003;348(7):651-656.
37. Gerberding JL. Hospital-onset infections: a patient safety issue. Ann Intern Med. 2002;137(8):665-670.
38. Shulman L, Ost D. Managing infection in the critical care unit: how can infection control make the ICU safe? Crit Care Clin. 2005;21(1):111-128, ix.
39. Clarke SP, Rockett JL, Sloane DM, Aiken LH. Organizational climate, staffing, and safety equipment as predictors of needlestick injuries and near-misses in hospital nurses. Am J Infect Control. 2002;30(4):207-216.
40. Gershon RR, Karkashian CD, Grosch JW, et al. Hospital safety climate and its relationship with safe work practices and workplace exposure incidents. Am J Infect Control. 2000;28(3):211-221.
41. Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospitalwide programme to improve compliance with hand hygiene: Infection Control Programme. Lancet. 2000;356(9238):1307-1312.
42. Sherertz RJ, Ely EW, Westbrook DM, et al. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med. 2000;132(8):641-648.
43. Vaughn TE, McCoy KD, Beekmann SE, Woolson RE, Torner JC, Doebbeling BN. Factors promoting consistent adherence to safe needle precautions among hospital workers. Infect Control Hosp Epidemiol. 2004;25(7):548-555.
44. Anderson BJ. Skin infections inMinnesota high school state tournament wrestlers: 1997-2006. Clin J Sport Med. 2007;17(6):478-480.
45. Duckro AN, Blom DW, Lyle EA, Weinstein RA, Hayden MK. Transfer of vancomycin-resistant enterococci via health care worker hands. Arch Intern Med. 2005;165(3):302-307.
46. Hota B. Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection? Clin Infect Dis. 2004;39(8):1182-1189.
47. Rutala WA, Weber DJ. Disinfection and sterilization in health care facilities: what clinicians need to know. Clin Infect Dis. 2004;39(5):702-709.
48. Centers for Disease Control and Prevention. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/ SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR Morb Mortal Wkly Rep. 2002;51(RR-16):1-45.
49. Larson E. A causal link between handwashing and risk of infection? Examination of the evidence. Infect Control Hosp Epidemiol. 1988;9(1):28-36.
50. Boyce JM. Scientific Basis for Handwashing With Alcohol And Other Waterless Antiseptic Principles and Practices in Healthcare Facilities. Washington, DC: Association for Professionals in Infection Control and Epidemiology; 2001.
51. Maury E, Alzieu M, Baudel JL, et al. Availability of an alcohol solution can improve hand disinfection compliance in an intensive care unit. Am J Respir Crit Care Med. 2000;162(1):324-327.
52. Ehrenkranz NJ, Alfonso BC. Failure of bland soap handwash to prevent hand transfer of patient bacteria to urethral catheters. Infect Control Hosp Epidemiol. 1991;12(11):654-662.
53. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989;320(4):204-210.
54. Mortimer EA Jr, Lipsitz PJ, Wolinsky E, Gonzaga AJ, Rammelkamp CH Jr. Transmission of staphylococci between newborns: importance of the hands to personnel. Am J Dis Child. 1962;104(3): 289-295.
55. Olsen RJ, Lynch P, Coyle MB, Cummings J, Bokete T, Stamm WE. Examination gloves as barriers to hand contamination in clinical practice. JAMA. 1993;270(3):350-353.
56. Tenorio AR, Badri SM, Sahgal NB, et al. Effectiveness of gloves in the prevention of hand carriage of vancomycin-resistant Enterococcus species by health care workers after patient care. Clin Infect Dis. 2001;32(5):826-829.
57. Cordoro KM, Ganz JE. Training room management of medical conditions: sports dermatology. Clin Sports Med. 2005;24(3):565-598, viii-ix.
58. Luke A, d'Hemecourt P. Prevention of infectious diseases in athletes. Clin Sports Med. 2007;26(3):321-344.
59. Nguyen DM, Mascola L, Brancoft E. Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerg Infect Dis. 2005;11(4):526-532.
60. Michalsen A, Delclos GL, Felknor SA, et al. Compliance with universal precautions among physicians. J Occup Environ Med. 1997;39(2):130-137.
61. Pleacher MD, Dexter WW. Cutaneous fungal and viral infections in athletes. Clin Sports Med. 2007;26(3):397-411.
62. Basler RS. Skin problems in athletics. In: Mellion MB, Walsh WM, Madden C, eds. Team Physician's Handbook. Philadelphia, PA: Hanley & Belfus; 2002:311-325.
63. Beller M, Gessner BD. An outbreak of tinea corporis gladiatorum on a high school wrestling team. J AmAcad Dermatol. 1994;31(2, pt 1): 197-201.
64. Vasily DB, Foley JJ. Guidelines for disposition of skin infections. In: Halpin T, ed. NCAA 2004 Division I Wrestling Championships Handbook. Indianapolis, IN: National Collegiate Athletic Association; 2004:21-23.
65. Kohl TD, Martin DC, Berger MS. Comparison of topical and oral treatments for tinea gladiatorum. Clin J Sport Med. 1999;9(3): 161-166.
66. Fitzpatrick TB, Johnson RA, Wolff K, eds. Cutaneous Fungal Infections. 3rd ed. New York, NY: McGraw-Hill; 1997.
67. Adams BB. New strategies for the diagnosis, treatment, and prevention of herpes simplex in contact sports. Curr Sports Med Rep. 2004;3(5):277-283.
68. Anderson BJ. The effectiveness of valacyclovir in preventing reactivation of herpes gladiatorum in wrestlers. Clin J Sport Med. 1999;9(2):86-90.
69. Balfour HH Jr. Antiviral drugs.NEngl JMed. 1999;340(16):1255-1268.
70. Becker TM. Herpes gladiatorum: a growing problem in sports medicine. Cutis. 1992;50(2):150-152.
71. Halstead ME, Bernhardt DT. Common infections in the young athlete. Pediatr Ann. 2002;31(1):42-48.
72. Marques AR. Herpes Simplex. Vol 2. 6th ed. New York, NY: McGraw Hill; 2003.
73. Rogers M, Barnetson RSC. Diseases of the skin. In: Campbell AGM, McIntosh N, eds. Forfar and Arneil's Textbook of Pediatrics. 5th ed. New York, NY: Churchill Livingstone; 1998 1633-1635.
74. Barton SE, Chard S. Facial molluscum: treatment with cryotherapy and podophyllotoxin. Int J STD AIDS. 2002;13(4):277-278.
75. Brown J, Janniger CK, Schwartz RA, Silverberg NB. Childhood molluscum contagiosum. Int J Dermatol. 2006;45(2):93-99.
76. Campanelli A, Krischer J, Saurat JH. Topical application of imiquimod and associated fever in children. J Am Acad Dermatol. 2005;52(1):E1.
77. Hancox JG, Jackson J, McCagh S. Treatment of molluscum contagiosum with the pulsed dye laser over a 28-month period. Cutis. 2003;71(5):414-416.
78. Kakourou T, Zachariades A, Anastasiou T, Architectonidou E, Georgala S, Theodoridou M. Molluscum contagiosum in Greek children: a case series. Int J Dermatol. 2005;44(3):221-223.
79. Leslie KS, Dootson G, Sterling JC. Topical salicylic acid gel as a treatment for molluscum contagiosum in children. J Dermatolog Treat. 2005;16(5-6):336-340.
80. Lowy DR. Molluscum contagiosum. In: Fitzpatrick TB, Freedberg IM, eds. Fitzpatrick's Dermatology in General Medicine. Vol 2. 5th ed. New York, NY: McGraw-Hill; 1999:2478-2481.
81. Ross GL, Orchard DC. Combination topical treatment of molluscum contagiosum with cantharidin and imiquimod 5% in children: a case series of 16 patients. Australas J Dermatol. 2004;45(2):100-102.
82. Adams BB. Sports dermatology. Adolesc Med. 2001;12(2):vii, 305322.
83. Koning S, Verhagen AP, van Suijlekom-Smit LWA, Morris A, Butler CC, van der Wouden JC. Interventions for impetigo. Cochrane Database Syst Rev. 2004, (2):CD003261. doi: 10./002/ 14651858.CD003261.pub2.
84. Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA. Strategies for clinical management of MRSA in the community: summary of an experts' meeting convened by the Centers for Disease Control and Prevention, 2006. http://www.cdc.gov/ncidod/ dhqp/ar-mrsa-ca.html. Accessed March 24, 2010.
85. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339(8):520-532.
86. Daum RS. Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med. 2007;357(4):380-390.
87. Rihn JA,MichaelsMG, Harner CD. Community-acquired methicillinresistant Staphylococcus aureus: an emerging problem in the athletic population. Am J Sports Med. 2005;33(12):1924-1929.
88. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352(14):1436-1444.
89. Iyer S, Jones DH. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a retrospective analysis of clinical presentation and treatment of a local outbreak. J Am Acad Dermatol. 2004;50(6):854-858.
90. Jones ME, Critchley IA, Karlowsky JA, et al. In vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IV. Antimicrob Agents Chemother. 2002;46(6):1651-1657.
91. Kaplan SL. Treatment of community-associated methicillinresistant Staphylococcus aureus infections. Pediatr Infect Dis J. 2005;24(5):457-458.
92. Martinez-Aguilar G, Hammerman WA, Mason EO Jr, Kaplan SL. Clindamycin treatment of invasive infections caused by communityacquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J. 2003;22(7):593-598.
93. Postier RG, Green SL, Klein SR, Ellis-Grosse EJ, Loh E. Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients. Clin Ther. 2004;26(5):704-714.
94. Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 4th ed. Philadelphia, PA: Mosby; 2004.
95. Habif TP, Campbell JLJ, Chapman MS, Dinulos JGH, Zug KA. Skin Disease: Diagnosis and Treatment. Philadelphia, PA: Elsevier; 2005.
96. Hughes WT. The athlete: an immunocompromised host. Adv Pediatr Infect Dis. 1997;13:79-99.
97. Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in health care settings. Clin Infect Dis. 2003;37(8):1094-1101.
98. Hall CB. Nosocomial respiratory syncytial virus infections: the "Cold War" has not ended. Clin Infect Dis. 2000;31(2):590-596.
99. Saiman L, Siegel J; Cystic Fibrosis Foundation. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol. 2003;24(5)(suppl):S6-S52.
100. Varia M, Wilson S, Sarwal S, et al. Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. CMAJ. 2003;169(4):285-292.
101. Munoz FM, Ong LT, Seavy D, Medina D, Correa A, Starke JR. Tuberculosis among adult visitors of children with suspected tuberculosis and employees at a children's hospital. Infect Control Hosp Epidemiol. 2002;23(10):568-572.
102. Osterholm MT, Hedberg CW, Moore KA. The epidemiology of infectious diseases. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 5th ed. Philadelphia, PA: Churchill Livingstone; 2000:161-163.
103. Pate RR, Trost SG, Levin S, Dowda M. Sports participation and health-related behaviors among US youth. Arch Pediatr Adolesc Med. 2000;154(9):904-911.
104. Centers for Disease Control and Prevention (CDC). Nosocomial hepatitis B virus infection associated with reusable fingerstick blood sampling devices-Ohio and New York City, 1996. MMWR Morb Mortal Wkly Rep. 1997;46(10):217-221.
105. Centers for Disease Control and Prevention (CDC). Transmission of hepatitis B virus among persons undergoing blood glucose monitoring in long-term-care facilities-Mississippi, North Carolina, and Los Angeles County, California, 2003-2004. MMWR Morb Mortal Wkly Rep. 2005;54(9):220-223.
106. Desenclos JC, Bourdiol-Razes M, Rolin B, et al. Hepatitis C in a ward for cystic fibrosis and diabetic patients: possible transmission by spring-loaded finger-stick devices for self-monitoring of capillary blood glucose. Infect Control Hosp Epidemiol. 2001;22(11):701-707.
107. Kirschke DL, Jones TF, Craig AS, et al. Pseudomonas aeruginosa and Serratia marcescens contamination associated with a manufacturing defect in bronchoscopes. N Engl J Med. 2003;348(3):214-220.
108. Schelenz S, French G. An outbreak of multidrug-resistant Pseudomonas aeruginosa infection associated with contamination of bronchoscopes and an endoscope washer-disinfector. J Hosp Infect. 2000;46(1):23-30.
109. Weber DJ, Rutala WA. Lessons from outbreaks associated with bronchoscopy. Infect Control Hosp Epidemiol. 2001;22(7):403-408.
110. Perry C, Marshall R, Jones E. Bacterial contamination of uniforms. J Hosp Infect. 2001;48(3):238-241.
111. Zachary KC, Bayne PS, Morrison VJ, Ford DS, Silver LC, Hooper DC. Contamination of gowns, gloves, and stethoscopes with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 2001;22(9):560-564.
112. Papineni RS, Rosenthal FS. The size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med. 1997;10(2):105-116.
113. Bloch AB, Orenstein WA, Ewing WM, et al. Measles outbreak in a pediatric practice: airborne transmission in an office setting. Pediatrics. 1985;75(4):676-683.
114. Coronado VG, Beck-Sague CM, Hutton MD, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis. 1993;168(4):1052-1055.
115. Widmer AF. Replace hand washing with use of a waterless alcohol hand rub? Clin Infect Dis. 2000;31(1):136-143.
116. Doebbeling BN, Li N, Wenzel RP. An outbreak of hepatitis A among health care workers: risk factors for transmission. Am J Public Health. 1993;83(12):1679-1684.
117. Rodriguez EM, Parrott C, Rolka H, Monroe SS, Dwyer DM. An outbreak of viral gastroenteritis in a nursing home: importance of excluding ill employees. Infect Control Hosp Epidemiol. 1996;17(9): 587-592.
118. Standaert SM, Hutcheson RH, Schaffner W. Nosocomial transmission of Salmonella gastroenteritis to laundry workers in a nursing home. Infect Control Hosp Epidemiol. 1994;15(1):22-26.
119. Mayfield JL, Leet T, Miller J, Mundy LM. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis. 2000;31(4):995-1000.
120. Denton M, Wilcox MH, Parnell P, et al. Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit. J Hosp Infect. 2004;56(2): 106-110.
121. Eun HC, Lee AY, Lee YS. Sodium hypochlorite dermatitis. Contact Dermatitis. 1984;11(1):45.
122. Hostynek JJ, Wilhelm KP, Cua AB, Maibach HI. Irritation factors of sodium hypochlorite solutions in human skin. Contact Dermatitis. 1990;23(5):316-324.
123. Osmundsen PE. Contact dermatitis due to sodium hypochlorite. Contact Dermatitis. 1978;4(3):177-178.
124. Murphy GF. The skin. In: Cotran RS, Kumar V, Collins T, eds. Robbins Pathologic Basis of Disease. 6th ed. Philadelphia, PA: WB Saunders; 1999:1170-1213.
125. Adams BB. Tinea corporis gladiatorum. J Am Acad Dermatol. 2002;47(2):286-290.
126. Foster KW, Ghannoum MA, Elewski BE. Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002. J Am Acad Dermatol. 2004;50(5):748-752.
127. Auger P, Marquis G, Joly J, Attye A. Epidemiology of tinea pedis in marathon runners: prevalence of occult athlete's foot. Mycoses. 1993;36(1-2):35-41.
128. Becker TM, Kodsi R, Bailey P, Lee F, Levandowski R, Nahmias AJ. Grappling with herpes: herpes gladiatorum. Am J Sports Med. 1988;16(6):665-669.
129. Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for superficial mycotic infections of the skin: tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis. Guidelines/Outcomes Committee. American Academy of Dermatology. J Am Acad Dermatol. 1996;34(2, pt 1):282-286.
130. Hradil E, Hersle K, Nordin P, Faergemann J. An epidemic of tinea corporis caused by Trichophyton tonsurans among wrestlers in Sweden. Acta Derm Venereol. 1995;75(4):305-306.
131. Kohl TD, Giesen DP, Moyer J Jr, Lisney M. Tinea gladiatorum: Pennsylvania's experience. Clin J Sport Med. 2002;12(3):165-171.
132. Kohl TD, Martin DC, Nemeth R, Hill T, Evans D. Fluconazole for the prevention and treatment of tinea gladiatorum. Pediatr Infect Dis J. 2000;19(8):717-722.
133. Frieden IJ, Howard R. Tinea capitis: epidemiology, diagnosis, treatment, and control. J Am Acad Dermatol. 1994;31(3, pt 2): S42-S46.
134. Kohl TD, Lisney M. Tinea gladiatorum: wrestling's emerging foe. Sports Med. 2000;29(6):439-447.
135. el Fari M, Graser Y, Presber W, Tietz HJ. An epidemic of tinea corporis caused by Trichophyton tonsurans among children (wrestlers) in Germany. Mycoses. 2000;43(5):191-196.
136. Belongia EA, Goodman JL, Holland EJ, et al. An outbreak of herpes gladiatorum at a high-school wrestling camp. N Engl J Med. 1991;325(13):906-910.
137. Reinberg J, Ailor SK, Dyer JA. Common sports-related dermatologic infections. Mo Med. 2007;104(2):119-123.
138. Oxman M. Herpes simplex virus. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious Diseases. 2nd ed. Philadelphia, PA: WB Saunders; 1998:2022-2062.
139. Selling B, Kibrick S. An outbreak of herpes simplex among wrestlers (herpes gladiatorum). N Engl J Med. 1964;270:979-982.
140. Centers for Disease Control and Prevention. Herpes gladiatorum at a high school wrestling camp: Minnesota. MMWR Morb Mortal Wkly Rep. 1990;39(5):69-71.
141. Holland EJ, Mahanti RL, Belongia EA, et al. Ocular involvement in an outbreak of herpes gladiatorum. Am J Ophthalmol. 1992;114(6): 680-684.
142. Whitley RJ, Kimberlin DW, Roizman B. Herpes simplex viruses. Clin Infect Dis. 1998;26(3):541-553.
143. da Silva LM, Guimaraes AL, Victoria JM, Gomes CC, Gomez RS. Herpes simplex virus type 1 shedding in the oral cavity of seropositive patients. Oral Dis. 2005;11(1):13-16.
144. Stalkup J, Yeung-Yue K, Brentjens M. Human herpes viruses. In: Bolognia J, Jorizzo J, Rapini R, eds. Dermatology. New York, NY: Mosby; 2003:1235-1253.
145. Anderson BJ. Valacyclovir to expedite the clearance of recurrent herpes gladiatorum. Clin J Sport Med. 2005;15(5):364-366.
146. Molino AC, Fleischer AB Jr, Feldman SR. Patient demographics and utilization of health care services for molluscum contagiosum. Pediatr Dermatol. 2004;21(6):628-632.
147. Niizeki K, Kano O, Kondo Y. An epidemic study of molluscum contagiosum: relationship to swimming. Dermatologica. 1984;169(4): 197-198.
148. Overfield TM, Brody JA. An epidemiologic study of molluscum contagiosum in Anchorage, Alaska. J Pediatr. 1966;69(4): 640-642.
149. Koning S, Bruijnzeels MA, van Suijlekom-Smit LW, van der Wouden JC. Molluscum contagiosum in Dutch general practice. Br J Gen Pract. 1994;44(386):417-419.
150. Relyveld J, Bergink AH, Nijhuis HGJ. Epidemiologica notes: leg ulcers, warts and dying circumstances. Huisarts en Wetenschap. 1988;31:266-267.
151. Fujisawa S, Ishizaka N, Morioka S, Usami Y, Ariga T. Aftercare of medical check-up. Pediatr Dermatol. 1982;5:129.
152. Nardi G. Molluschi contagiosi e lottatori. Dermosifilograf. 1934;9: 110-116.
153. Keipert JA. The association of molluscum contagiosum and infantile eczema. Med J Aust. 1971;1(5):267-270.
154. Beaulieu P, Pepin E, Aboucaya P, et al. Molluscum contagiosum: epidemiological study of 452 cases in private practice [Molluscum contagiosum etude épidémiologique de 452 observations en pratique libérale]. Nouv Dermatol. 2000;19(3):231.
155. Euvrard S, Kanitakis J, Cochat P, Cambazard F, Claudy A. Skin diseases in children with organ transplants. J Am Acad Dermatol. 2001;44(6):932-939.
156. Gottlieb SL, Myskowski PL. Molluscum contagiosum. Int J Dermatol. 1994;33(7):453-461.
157. HusakR,Garbe C,OrfanosCE.Mollusca contagiosa inHIV infection. Clinical manifestation, relation to immune status and prognostic value in 39 patients [Mollusca contagiosa bei HIV-Infektion Klinische Manifestation, Beziehung zum Immunstatus und prognostische Wertigkeit bei 39 Patienten]. Hautarzt. 1997;48(2):103-109.
158. Sturt RJ, Muller HK, Francis GD. Molluscum contagiosum in villages of the West Sepik District of New Guinea. Med J Aust. 1971;2(15):751-754.
159. Sterling JC, Kurtz JB. Viral infections. In: Champion RH, Burton JL, Ebling FJG, eds. Rook/Wilkinson/Ebling Textbook of Dermatology. Vol 6. Oxford, United Kingdom: Blackwell; 1998: 1005-1008.
160. Kress DW. Molluscum contagiosum: an evidence-based review. In: Nonmelanoma Skin Cancer and Cutaneous Viral Diseases: An Update. Rockville, MD: Elsevier/International Medical News Group and Skin Disease Education Foundation; 2007:8-10.
161. Powell FC. Sports dermatology. J Eur Acad Dermatol Venerol. 1994;3(1):1-15.
162. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10(3):505-520.
163. Centers for Disease Control. Staphylococcal infections in wrestlers: Iowa. MMWR Morb Mortal Wkly Rep. 1962;11:152.
164. Barton LL, Friedman AD. Impetigo: a reassessment of etiology and therapy. Pediatr Dermatol. 1987;4(3):185-188.
165. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41(10):1373-1406.
166. Barrett FF, McGehee RF Jr, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital: bacteriologic and epidemiologic observations. N Engl J Med. 1968;279(9): 441-448.
167. Ma XX, Ito T, Tiensasitorn C, et al. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother. 2002;46(4):1147- 1152.
168. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290(22):2976-2984.
169. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillinresistant Staphylococcus aureus infections in the United States. JAMA. 2007;298(15):1763-1771.
170. Rihn JA, Posfay-Barbe K, Harner CD, et al. Community-acquired methicillin-resistant Staphylococcus aureus outbreak in a local high school football team unsuccessful interventions. Pediatr Infect Dis J. 2005;24(9):841-843.
171. Centers for Disease Control and Prevention (CDC). Methicillinresistant Staphylococcus aureus infections among competitive sports participants: Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep. 2003; 52(33):793-795.
172. Selvey LA, Whitby M, Johnson B. Nosocomial methicillin-resistant Staphylococcus aureus bacteremia: is it any worse than nosocomial methicillin-sensitive Staphylococcus aureus bacteremia? Infect Control Hosp Epidemiol. 2000;21(10):645-648.
173. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S aureus infections among patients in the emergency department. N Engl J Med. 2006;355(7):666-674.
174. Purcell K, Fergie J. Epidemic of community-acquired methicillinresistant Staphylococcus aureus infections: a 14-year study at Driscoll Children's Hospital. Arch Pediatr Adolesc Med. 2005; 159(10):980-985.
175. Kazakova SV, Hageman JC, Matava M, et al. A clone of methicillin- resistant Staphylococcus aureus among professional football players. N Engl J Med. 2005;352(5):468-475.
176. Beam JW, Buckley B. Community-acquired methicillin-resistant Staphylococcus aureus: prevalence and risk factors. J Athl Train. 2006;41(3):337-340.
177. Said-Salim B, Mathema B, Kreiswirth BN. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen. Infect Control Hosp Epidemiol. 2003;24(6):451-455.
178. Hidron AI, Kourbatova EV, Halvosa JS, et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of communityassociated MRSA nasal carriage. Clin Infect Dis. 2005;41(2):159-166.
179. Baggett HC, Hennessy TW, Leman R, et al. An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. Infect Control Hosp Epidemiol. 2003;24(6):397-402.
180. Laupland KB, Conly JM. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin Infect Dis. 2003; 37(7):933-938.
181. Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis. 2004;39(7):971-979.